For the past 24 years, Professor Lynn Morris has been researching the virological and immunological aspects of South African HIV-1 subtype C infection, making significant contributions to our understanding of how the HIV antibody response develops. HIV vaccine development is now a major focus of her research and she is responsible for performing neutralising antibody assays on human clinical trials conducted in South Africa. She heads the HIV Virology Section at the National Institute for Communicable Diseases and holds a joint appointment as Research Professor at the University of the Witwatersrand, where she also completed her undergraduate studies.
She received her DPhil from the University of Oxford, where after she completed a post-doctoral fellowship at The Walter and Eliza Hall Institute of Medical Research in Australia before returning to South Africa. She has supervised 25 PhD and MSc students and has published over 200 papers in peer-reviewed Journals, holding a current author H-Index of 49.
She received several awards for her contribution to HIV vaccine research, which include the University of the Witwatersrand’s Vice Chancellor Research Award and the South African Medical Research Council’s Gold Merit Award. She is also listed on the Thompsons Reuters 2015 ISIS list of the 3000 highest cited researchers in the world.